Skip to main navigation Skip to search Skip to main content

Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis

V C McAlister, E Haddad, E Renouf, R A Malthaner, M S Kjaer, L L Gluud

235 Citations (Scopus)

Abstract

A systematic review of randomized clinical trials (RCT) was undertaken to evaluate the beneficial and harmful effects of immunosuppression with cyclosporin versus tacrolimus for liver transplanted patients. MEDLINE, EMBASE, Cochrane Central and Hepato-Biliary Group Controlled Trials Registers were searched. Using fixed and random effects model, relative risk (RR), values
Original languageEnglish
JournalAmerican Journal of Transplantation
Volume6
Issue number7
Pages (from-to)1578-85
Number of pages8
ISSN1600-6135
DOIs
Publication statusPublished - Jul 2006

Keywords

  • Acute Disease
  • Cyclosporine
  • Follow-Up Studies
  • Graft Rejection
  • Humans
  • Immunosuppressive Agents
  • Liver Transplantation
  • Risk Factors
  • Tacrolimus

Fingerprint

Dive into the research topics of 'Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis'. Together they form a unique fingerprint.

Cite this